Literature DB >> 23395157

Comparison of arteriovenous fistulas and arteriovenous grafts in patients with favorable vascular anatomy and equivalent access to health care: is a reappraisal of the Fistula First Initiative indicated?

David E Disbrow1, David L Cull, Christopher G Carsten, Seung Koo Yang, Brent L Johnson, Gail P Keahey.   

Abstract

BACKGROUND: Initiatives to increase arteriovenous fistula (AVF) use are based on studies that show that AVFs require fewer interventions and have better patency than arteriovenous grafts (AVGs). Because patients who receive AVFs typically have more favorable vascular anatomy and are referred earlier for access placement than those who receive AVGs, the advantages of AVF might be overestimated. We compared outcomes for AVFs and AVGs in patients with equivalent vascular anatomy who were on dialysis via catheter at the time of vascular access placement. STUDY
DESIGN: The study included patients who underwent placement of a first-time AVF or AVG between 2006 and 2009, who were on dialysis via catheter at the time of access placement, and who had favorable arterial and venous (>3 mm) anatomy. Outcomes for AVF and AVG were compared.
RESULTS: Eighty-nine AVF and 59 AVG patients met study inclusion criteria. Similar secondary patency was achieved by AVG and AVF at 12 (72% vs 71%) and 24 months (57% vs 62%), respectively (p = 0.96). The number of interventions required to maintain patency for AVF (n = 1; range 0 to 10) and AVG (n = 1; range 0 to 11) were not different (p = 0.36). However, the number of catheter days to first access use was more than doubled in the AVF group (median 81 days) compared with the AVG group (median 38 days; p < 0.001).
CONCLUSIONS: For patients who are receiving dialysis via catheter at the time of access placement, the maturation time, risk of nonmaturation, and interventions required to achieve a functional AVF can negate its benefits over AVG. A fistula first approach might not always apply to patients who are already on dialysis when referred for chronic access placement.
Copyright © 2013 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23395157     DOI: 10.1016/j.jamcollsurg.2012.12.021

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

Review 1.  Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure.

Authors:  Karen Woo; Jesus Ulloa; Michael Allon; Christopher G Carsten; Eric S Chemla; Mitchell L Henry; Thomas S Huber; Jeffrey H Lawson; Charmaine E Lok; Eric K Peden; Larry Scher; Anton Sidawy; Melinda Maggard-Gibbons; David Cull
Journal:  J Vasc Surg       Date:  2017-02-17       Impact factor: 4.268

2.  The Effect of Risk of Maturation Failure and Access Type on Arteriovenous Access-Related Costs among Hemodialysis Patients.

Authors:  Sarah D Kosa; Amiram Gafni; Lehana Thabane; Charmaine E Lok
Journal:  Kidney360       Date:  2020-03-13

3.  Distinct subsets of T cells and macrophages impact venous remodeling during arteriovenous fistula maturation.

Authors:  Yutaka Matsubara; Gathe Kiwan; Arash Fereydooni; John Langford; Alan Dardik
Journal:  JVS Vasc Sci       Date:  2020-09-01

4.  Arteriovenous Access Failure, Stenosis, and Thrombosis.

Authors:  Jennifer M MacRae; Christine Dipchand; Matthew Oliver; Louise Moist; Charmaine Lok; Edward Clark; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Rick Luscombe; Lisa M Miller
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

5.  Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.

Authors:  Yutaka Matsubara (松原裕); Gathe Kiwan; Jia Liu (刘佳); Luis Gonzalez; John Langford; Mingjie Gao (高明杰); Xixiang Gao (高喜翔); Ryosuke Taniguchi (谷口良輔); Bogdan Yatsula; Tadashi Furuyama (古山正); Takuya Matsumoto (松本拓也); Kimihiro Komori (古森公浩); Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 10.514

6.  Use of short prosthesis segments for brachiocephalic arteriovenous fistulas in elderly hemodialysis population.

Authors:  Jerzy Głowiński; Jolanta Małyszko; Irena Głowińska; Michał Myśliwiec
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

7.  Delayed conversion from central venous catheter to non-catheter hemodialysis access associates with an increased risk of death: A retrospective cohort study based on data from a large dialysis provider.

Authors:  Jochen G Raimann; Fang-I Chu; Sean Kalloo; Hanjie Zhang; Frank Maddux; Yuedong Wang; Peter Kotanko
Journal:  Hemodial Int       Date:  2020-03-05       Impact factor: 1.812

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.